InvestorsHub Logo
Followers 5
Posts 463
Boards Moderated 0
Alias Born 11/21/2016

Re: None

Saturday, 09/30/2017 12:16:05 AM

Saturday, September 30, 2017 12:16:05 AM

Post# of 2676
I have had two meetings with the VP this week. Pre and post news. Discussed all sorts of things going forward! This is news on a global level that i believe only comes a few times in a lifetime.

Right now stuck shorts are in control beating down the price to cover there goof! But long term it means nothing!

AO still is a 75% possibility for a restructured phase 2 Before the end of December along with news of Zyn001 positive phase 1 and initiating ph2. Again Last few weeks of the year.

Talked finance and FXS p3 will only cost about 5-10 million dollars with 100 participants and OA approx 20 million w 300 participants so 30 million needed to secure the approval path!

-70 mill in cash to last till 2019
-Better data then any other spectrum drug in history!
-No debt
-Great management team!
-Orphan drug with 7 years exclusive marketing
-patent protection 2033
-great pipeline
-FDA experience!

What more could anyone possibly ask for?

Hang in there guys! This one goes for platinum!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News